Canada markets closed

Dr. Reddy's Laboratories Limited (RDY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
68.92+0.21 (+0.31%)
At close: 04:00PM EDT
68.92 0.00 (0.00%)
After hours: 05:49PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in INR. All numbers in thousands
Breakdown
ttm
2024-03-31
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Total Revenue
279,164,000
-
245,879,000
214,391,000
189,722,000
174,600,000
Cost of Revenue
82,087,000
-
106,536,000
100,551,000
86,645,000
80,591,000
Gross Profit
197,077,000
-
139,343,000
113,840,000
103,077,000
94,009,000
Operating Expenses
Research Development
-
-
19,381,000
17,482,000
16,541,000
15,410,000
Selling General and Administrative
118,690,000
-
68,026,000
62,081,000
54,650,000
50,129,000
Total Operating Expenses
132,443,000
-
80,289,000
77,921,000
70,167,000
61,239,000
Operating Income or Loss
64,634,000
-
59,054,000
35,919,000
32,910,000
32,770,000
Interest Expense
1,711,000
-
1,428,000
958,000
970,000
983,000
Total Other Income/Expenses Net
9,087,000
-
1,561,000
-3,628,000
-6,353,000
-14,648,000
Income Before Tax
72,010,000
-
60,367,000
32,298,000
26,413,000
18,032,000
Income Tax Expense
16,231,000
-
15,300,000
8,730,000
9,175,000
-1,466,000
Income from Continuing Operations
55,779,000
-
45,067,000
23,568,000
17,238,000
19,498,000
Net Income
55,779,000
-
45,067,000
23,568,000
17,238,000
19,498,000
Net Income available to common shareholders
55,779,000
-
45,067,000
23,568,000
17,238,000
19,498,000
Basic EPS
306.20
335.22
271.43
142.08
103.94
-
Diluted EPS
305.55
334.59
270.85
141.69
103.65
-
Basic Average Shares
166,178
166,395
166,035
165,883
165,844
-
Diluted Average Shares
166,530
166,709
166,388
166,339
166,316
-